Memantine linked to lower neuron-specific enolase in TBI

July 27, 2017

(HealthDay)—For patients with moderate traumatic brain injury (TBI), memantine is associated with reduced neuronal damage, as assessed by serum levels of neuron-specific enolase (NSE), according to a study published online July 19 in the Journal of Clinical Pharmacology.

Majid Mokhtari, M.D., from Imam Hossein Hospital in Tehran, Iran, and colleagues randomized 41 to either a control group which received standard TBI management (19 patients) or a treatment group which received enteral 30 mg twice daily for seven days alongside standard management (22 patients). During the study, patients' clinical data, Glasgow Coma Scale (GCS), findings of head computed tomography, and serum NSE levels were obtained.

The researchers found that on days three and seven, the mean serum NSE levels were 7.95 ± 2.86 and 12.33 ± 7.09 ng/mL (P = 0.05) and 5.03 ± 3.25 and 10.04 ± 5.72 ng/mL (P = 0.03), respectively, for the memantine and control groups. On day three, the mean GCS score was 12.3 ± 2.0 and 10.9 ± 1.9 in the memantine and control groups, respectively (P = 0.03). There was a negative correlation for serum NSE levels and GCS changes (r = −0.368; P = 0.02).

"Patients with moderate TBI who received memantine had significantly reduced serum NSE levels by day seven and marked improvement in their GCS scores on day three of the study," the authors write.

Explore further: Alzheimer's drug may help treat traumatic brain injury

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Alzheimer's drug may help treat traumatic brain injury

July 21, 2017
Traumatic brain injury (TBI) is a major cause of disability and death globally, but medications have generally failed to benefit patients. A new study found that memantine, a drug that is used to treat dementia associated ...

Memantine plus sertraline effective for major depressive disorder

November 7, 2016
(HealthDay)—The combination of memantine plus sertraline is efficacious for major depressive disorder, according to a study published online Nov. 3 in the Journal of Clinical Pharmacy and Therapeutics.

Evidence lacking for efficacy of memantine in treating mild Alzheimer's disease

April 11, 2011
An analysis of studies involving the drug memantine finds a lack of evidence for benefit when the drug is used to treat patients with mild Alzheimer disease, according to a report posted online today that will appear in the ...

Markers that predict omalizumab response identified

May 2, 2016
(HealthDay)—Baseline serum periostin levels and levels of serum free immunoglobulin E (IgE) during treatment follow-up may be useful in assessing response to omalizumab treatment for asthma, according to a study published ...

Acne-related depression, anxiety not tied to oxidative stress

June 26, 2017
(HealthDay)—High levels of anxiety and depression in patients with facial acne are not related to oxidative stress, according to a study published online June 20 in the Journal of Cosmetic Dermatology.

Serum periostin IDs comorbid chronic rhinosinusitis in asthma

March 21, 2017
(HealthDay)—For patients with asthma, serum periostin is useful for detecting chronic rhinosinusitis with nasal polyps, according to a study published online March 1 in the Annals of the American Thoracic Society.

Recommended for you

A multimodal intervention to reduce one of the most common healthcare-acquired infections

March 16, 2018
Surgical site infections are the most frequent health care-associated infections in developing countries. According to the World Health Organization (WHO), this type of infection can affect up to one-third of surgical patients ...

New imaging approach offers unprecedented views of staph infection

March 14, 2018
Eric Skaar, PhD, MPH, marvels at the images on his computer screen—3-D molecular-level views of infection in a mouse. "I'm pretty convinced that these are the most advanced images in infection biology," said Skaar, Ernest ...

Parasitic worms need their intestinal microflora too

March 14, 2018
Scientists at The University of Manchester have cast new light on a little understood group of worm infections, which collectively afflicts 1 in 4 people, mainly children—in the developing the world.

Compound scores key win in battle against antibiotic resistance

March 14, 2018
Researchers at Oregon State University have made a key advance in the fight against drug resistance, crafting a compound that genetically neutralizes a widespread bacterial pathogen's ability to thwart antibiotics.

Helicobacter creates immune system blind spot

March 13, 2018
The gastric bacterium H. pylori colonizes the stomachs of around half the human population and can lead to the development of gastric cancer. It is usually acquired in childhood and persists life-long, despite a strong inflammatory ...

Taking the jab (and the chill) out of vaccination

March 13, 2018
Scientists in Cairns (Australia) and Cardiff (Wales) have taken an important first step towards solving two problems that hinder access to vaccines: they need to be kept cool, and no one likes needles.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.